Medpace Holdings, Inc. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
Medpace Holdings, Inc. (MEDP) reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 505.00 thousand shares for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2016-11-03
- Medpace Holdings, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2016-09-30 was 505.00K shares.
- Medpace Holdings, Inc. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2015-09-30 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month |
|---|---|---|
| 2016-09-30 | 505.00K shares 10-Q · filed 2016-11-03 | 227.00K shares 10-Q · filed 2016-11-03 |
| 2015-09-30 | 0.00 shares 10-Q · filed 2016-11-03 | 0.00 shares 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |